Canada markets open in 5 hours 34 minutes

EyePoint Pharmaceuticals, Inc. (EYPT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.14+0.30 (+2.53%)
At close: 04:00PM EDT
12.33 +0.19 (+1.57%)
After hours: 06:50PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
50,019
46,018
41,404
36,939
34,437
Cost of Revenue
4,751
4,632
8,326
8,177
5,824
Gross Profit
45,268
41,386
33,078
28,762
28,613
Operating Expenses
Research Development
81,183
64,662
49,642
28,500
17,424
Selling General and Administrative
50,919
51,791
60,324
53,078
46,019
Total Operating Expenses
132,102
116,453
112,016
84,038
65,903
Operating Income or Loss
-86,834
-75,067
-78,938
-55,276
-37,290
Interest Expense
435
1,247
3,189
5,498
7,257
Total Other Income/Expenses Net
-
-1,347
-22,258
2,065
-905
Income Before Tax
-78,832
-70,712
-102,254
-58,417
-45,394
Income Tax Expense
-
83
0
-
-
Income from Continuing Operations
-78,915
-70,795
-102,254
-58,417
-45,394
Net Income
-78,915
-70,795
-102,254
-58,417
-45,394
Net Income available to common shareholders
-78,915
-70,795
-102,254
-58,417
-45,394
Basic EPS
-1.40
-1.82
-2.74
-2.03
-3.54
Diluted EPS
-1.40
-1.82
-2.74
-2.03
-3.54
Basic Average Shares
67,765
38,904
37,317
28,758
12,836
Diluted Average Shares
67,765
38,904
37,317
28,758
12,836